These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1484824)

  • 1. Liquid preparations for oral administration.
    Taylor D; Helliwell M
    Prof Nurse; 1992 Dec; 8(3):163-6. PubMed ID: 1484824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmaceutical suspensions, an effective drug form].
    Bashuara GS; Safiulina ZR; Pertsev IM; Duchidze NV
    Farm Zh; 1975; 30(6):27-34. PubMed ID: 765146
    [No Abstract]   [Full Text] [Related]  

  • 4. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
    Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
    N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of sulfadiazine oral liquids prepared from tablets and powder.
    Pathmanathan U; Halgrain D; Chiadmi F; Schlatter J; Vermerie N
    J Pharm Pharm Sci; 2004 Apr; 7(1):84-7. PubMed ID: 15144740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nursing practices about preparation and administration of oral solutions in psychiatry].
    Le Meur-Ringard C; Gaudoneix-Taieb M; Beauverie P
    Therapie; 2007; 62(6):489-98. PubMed ID: 18316015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryogenic liquids, nanoparticles, and microencapsulation.
    Purvis T; Vaughn JM; Rogers TL; Chen X; Overhoff KA; Sinswat P; Hu J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2006 Oct; 324(1):43-50. PubMed ID: 16814968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric formulations--getting to the heart of the problem.
    Standing JF; Tuleu C
    Int J Pharm; 2005 Aug; 300(1-2):56-66. PubMed ID: 15979830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmolality of oral drug solutions and suspensions.
    Dickerson RN; Melnik G
    Am J Hosp Pharm; 1988 Apr; 45(4):832-4. PubMed ID: 3376967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extemporaneous compounding activities and the associated informational needs of pharmacists.
    Crawford SY; Dombrowski SR
    Am J Hosp Pharm; 1991 Jun; 48(6):1205-10. PubMed ID: 1858798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
    Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
    Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Standard prescriptions for the formulation of medicinal preparations in pharmacies. I. Suspensions for dermal administration].
    Subert J; Kolár J; Vasková V
    Ceska Slov Farm; 2008 Apr; 57(2):55-7. PubMed ID: 18578413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The foreign particles in injectable solutions].
    Cavatorta L; Pietra E; Allievi R
    Boll Chim Farm; 1969 Aug; 108(8):488-98. PubMed ID: 5354286
    [No Abstract]   [Full Text] [Related]  

  • 19. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bulk compounding of technology of liquids and semi-solids.
    Schumacher GE
    Am J Hosp Pharm; 1969 Feb; 26(2):70-99. PubMed ID: 5766229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.